The retinal pigment epithelium (RPE) is the major barrier between the outer neural retina and the choroid, forming part of the blood retina barrier (BRB). Damage to the RPE cell and to the organization of the RPE sheet impairs the BRB, as seen in AMD, uveitis, retinal degenerations, and retinal detachment. Additionally, damage to the RPE can occur following subretinal surgery or subretinal injections. Extensive work by others with non-ocular epithelial monolayers indicates that such tissues respond to stress and restore their structure and function through a small number of protective mechanisms. Our preliminary experimental observations suggest that the RPE similarly responds to damage or disease, restoring the BRB via definable protective mechanisms. From these observations, we hypothesize: a) There are a limited number of responses that the RPE takes to restore the BRB; b) Each kind of response results in a unique pattern of RPE cell death; c) Each response type differs, thus modeling BRB repair must be flexible (Fig 1). For these reasons, we propose here to test for specific mechanisms that the RPE uses to respond to insult and to restore the BRB following chronic mild, moderate, and severe injury. While restoration of barrier functions has been investigated in Drosophila wings, lung alveoli, and throughout embryology, it has not been studied in the RPE sheet. Most research on epithelial monolayers, whether in RPE or in non-ocular tissue, uses 2- dimensional (2D) static or time-lapse motion photomicroscopy to study damage responses. In this project, we adapt clever software and mathematical tools from outside vision research that use quantitative spatiotemporal (4D: 3D in space & 1D in Time) dynamics to explore the damage responses of individual RPE cells and of the RPE sheet. Significance: Completion of these Aims will increase our understanding of spatiotemporal dynamics and biomechanics of repair of the BRB after short- or long-term, low- to high-level toxic insults to RPE cells. This new understanding of mechanisms will allow us to correct the loss of essential barrier function in blinding diseases by initiating early and inexpensive interventions.

Public Health Relevance

We propose to examine how retinal pigment epithelium (RPE) responds to insult in order to maintain the blood- retina barrier (BRB), and whether learning about these response pathways reveals therapeutic targets to mitigate damage, hasten RPE repair, and restore BRB function. We will mimic forms of macular and retinal degenerations by stressing mouse RPE or photoreceptor cells. Novel in vivo imaging of color-coded RPE cells together with image and statistical analyses and histopathological techniques will allow us to determine biomechanical mechanisms and predictive indicators of early RPE, neural retina, and choroid degeneration.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
1R01EY028450-01A1
Application #
9546294
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Neuhold, Lisa
Project Start
2018-06-01
Project End
2023-05-31
Budget Start
2018-06-01
Budget End
2019-05-31
Support Year
1
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Emory University
Department
Ophthalmology
Type
Schools of Medicine
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Wang, Jiaxing; Struebing, Felix L; Ferdous, Salma et al. (2018) Differential Exon Expression in a Large Family of Retinal Genes Is Regulated by a Single Trans Locus. Adv Exp Med Biol 1074:413-420
Henneman, Nathaniel F; Foster, Stephanie L; Chrenek, Micah A et al. (2018) Xanthohumol Protects Morphology and Function in a Mouse Model of Retinal Degeneration. Invest Ophthalmol Vis Sci 59:45-53
Gooding, Sarah W; Chrenek, Micah A; Ferdous, Salma et al. (2018) Set screw homogenization of murine ocular tissue, including the whole eye. Mol Vis 24:690-699
Kudelka, Matthew R; Grossniklaus, Hans E; Mandell, Kenneth J (2013) Emergence of dual VEGF and PDGF antagonists in the treatment of exudative age-related macular degeneration. Expert Rev Ophthalmol 8:475-484